G1 Therapeutics Inc (GTHX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2006 | |
| Sales | 0 | 0 | 0 | 522 | 0 |
| Gross Profit | N/A | N/A | N/A | 522 | N/A |
| Operating Expenses | 89,286 | 60,968 | 30,391 | 15,946 | 0 |
| Operating Income | -89,286 | -60,968 | -30,391 | -15,424 | N/A |
| Other Income | 3,998 | 847 | 100 | -4,839 | 0 |
| Pre-tax Income | -85,288 | -60,121 | -30,291 | -20,263 | 0 |
| Net Income Continuous | -85,288 | -60,121 | -30,291 | -20,263 | N/A |
| Net Income | $-85,288 | $-60,121 | $-30,291 | $-20,263 | $N/A |
| EPS Basic Total Ops | -2.56 | -3.57 | -23.33 | -16.13 | N/A |
| EPS Basic Continuous Ops | -2.56 | -3.30 | -20.37 | -15.07 | N/A |
| EPS Diluted Total Ops | -2.56 | -3.57 | -23.33 | -16.13 | N/A |
| EPS Diluted Continuous Ops | -2.56 | -3.30 | -20.37 | -15.07 | N/A |
| EPS Diluted Before Non-Recurring Items | -2.56 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-89,111 | $-60,879 | $-30,324 | $-15,382 | $N/A |